Your session is about to expire
← Back to Search
Behavioural Intervention
F3 Group for Depression
N/A
Waitlist Available
Led By Nicholas T Trapp, M.D.
Research Sponsored by Nicholas Trapp
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of major depressive disorder
Age between 18 and 90 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-assessment will be obtained within approximately 1 week of starting rtms. post-assessment will be obtained immediately following completion of rtms course, usually 4-6 weeks later.
Awards & highlights
Study Summary
This trial will test if different locations for administering rTMS treatment will have different effects for people with major depressive disorder.
Eligible Conditions
- Depression
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-assessment will be obtained within approximately 1 week of starting rtms. post-assessment will be obtained immediately following completion of rtms course, usually 4-6 weeks later.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-assessment will be obtained within approximately 1 week of starting rtms. post-assessment will be obtained immediately following completion of rtms course, usually 4-6 weeks later.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clinical Global Impression Scale
Cognitive measures
Emotion measures
+8 moreTrial Design
2Treatment groups
Active Control
Group I: F3 GroupActive Control1 Intervention
rTMS will be targeted at the left prefrontal scalp target identified as F3 according to the 10-20 EEG system.
Group II: 5.5cm Rule GroupActive Control1 Intervention
rTMS will be targeted at a left prefrontal target 5.5cm anterior to the primary motor strip identified on the scalp during motor threshold testing.
Find a Location
Who is running the clinical trial?
Nicholas TrappLead Sponsor
Nicholas T Trapp, M.D.Principal InvestigatorUniversity of Iowa
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger